NO914734D0 - 5-amino-5,6,7,8-tetrahydrokinoliner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter - Google Patents
5-amino-5,6,7,8-tetrahydrokinoliner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenterInfo
- Publication number
- NO914734D0 NO914734D0 NO914734A NO914734A NO914734D0 NO 914734 D0 NO914734 D0 NO 914734D0 NO 914734 A NO914734 A NO 914734A NO 914734 A NO914734 A NO 914734A NO 914734 D0 NO914734 D0 NO 914734D0
- Authority
- NO
- Norway
- Prior art keywords
- arylalkyl
- alkyl
- formula
- hydrogen
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/620,811 US5110815A (en) | 1990-12-03 | 1990-12-03 | 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO914734D0 true NO914734D0 (no) | 1991-12-02 |
| NO914734L NO914734L (no) | 1992-06-04 |
Family
ID=24487491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91914734A NO914734L (no) | 1990-12-03 | 1991-12-02 | 5-amino-5,6,7,8-tetrahydrokinoliner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5110815A (no) |
| EP (1) | EP0489379B1 (no) |
| JP (1) | JP3090514B2 (no) |
| KR (1) | KR100235506B1 (no) |
| AT (1) | ATE168371T1 (no) |
| AU (1) | AU639875B2 (no) |
| CA (1) | CA2056793C (no) |
| DE (1) | DE69129790T2 (no) |
| DK (1) | DK0489379T3 (no) |
| ES (1) | ES2119752T3 (no) |
| FI (1) | FI915653A (no) |
| IE (1) | IE914183A1 (no) |
| NO (1) | NO914734L (no) |
| NZ (1) | NZ240803A (no) |
| PT (1) | PT99674B (no) |
| TW (1) | TW211003B (no) |
| ZA (1) | ZA919480B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112566A (en) * | 1994-02-10 | 2000-10-31 | Wyeth John & Brother Ltd | Substituted quinolinones and pharmaceutical compositions containing them |
| IL112568A0 (en) * | 1994-02-10 | 1995-05-26 | Wyeth John & Brother Ltd | Substituted quinolines, their preparation and pharmaceutical compositions containing them |
| IL112567A (en) * | 1994-02-10 | 2000-02-29 | Wyeth John & Brother Ltd | Substituted quinolines their preparation and pharmaceutical compositions containing them |
| KR0158065B1 (ko) * | 1995-05-29 | 1998-12-01 | 스기야마 가즈히코 | 반도체 집적회로장치 및 그 제조방법 |
| KR100648869B1 (ko) | 1998-09-30 | 2007-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4789678A (en) * | 1986-08-25 | 1988-12-06 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds |
| US4942168A (en) * | 1987-07-13 | 1990-07-17 | Hoechst-Roussel Pharmaceuticals Inc. | Hydroxyquinoline amines, and method of enhancing memory in mammals |
| EP0361489A3 (en) * | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | Novel 3,4-diaminoquinoline and pyridine compounds |
| JPH0322011A (ja) * | 1989-06-19 | 1991-01-30 | Nec Corp | キーボード入力データ処理方式 |
-
1990
- 1990-12-03 US US07/620,811 patent/US5110815A/en not_active Expired - Lifetime
-
1991
- 1991-11-22 TW TW080109151A patent/TW211003B/zh active
- 1991-11-29 FI FI915653A patent/FI915653A/fi unknown
- 1991-11-29 NZ NZ24080391A patent/NZ240803A/en unknown
- 1991-12-02 AU AU88352/91A patent/AU639875B2/en not_active Expired - Fee Related
- 1991-12-02 JP JP03317805A patent/JP3090514B2/ja not_active Expired - Fee Related
- 1991-12-02 DK DK91120652T patent/DK0489379T3/da active
- 1991-12-02 DE DE69129790T patent/DE69129790T2/de not_active Expired - Fee Related
- 1991-12-02 NO NO91914734A patent/NO914734L/no unknown
- 1991-12-02 ZA ZA919480A patent/ZA919480B/xx unknown
- 1991-12-02 IE IE418391A patent/IE914183A1/en not_active IP Right Cessation
- 1991-12-02 CA CA002056793A patent/CA2056793C/en not_active Expired - Fee Related
- 1991-12-02 AT AT91120652T patent/ATE168371T1/de not_active IP Right Cessation
- 1991-12-02 EP EP91120652A patent/EP0489379B1/en not_active Expired - Lifetime
- 1991-12-02 ES ES91120652T patent/ES2119752T3/es not_active Expired - Lifetime
- 1991-12-03 PT PT99674A patent/PT99674B/pt not_active IP Right Cessation
- 1991-12-03 KR KR1019910022011A patent/KR100235506B1/ko not_active IP Right Cessation
-
1993
- 1993-03-19 US US08/035,335 patent/US5310914A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3090514B2 (ja) | 2000-09-25 |
| NZ240803A (en) | 1994-07-26 |
| JPH04290872A (ja) | 1992-10-15 |
| EP0489379B1 (en) | 1998-07-15 |
| TW211003B (no) | 1993-08-11 |
| FI915653A (fi) | 1992-06-04 |
| FI915653A0 (fi) | 1991-11-29 |
| CA2056793A1 (en) | 1992-06-04 |
| US5110815A (en) | 1992-05-05 |
| AU639875B2 (en) | 1993-08-05 |
| AU8835291A (en) | 1992-06-04 |
| KR100235506B1 (ko) | 1999-12-15 |
| ATE168371T1 (de) | 1998-08-15 |
| ZA919480B (en) | 1992-08-26 |
| CA2056793C (en) | 2003-03-11 |
| PT99674B (pt) | 1999-05-31 |
| KR920012036A (ko) | 1992-07-25 |
| NO914734L (no) | 1992-06-04 |
| US5310914A (en) | 1994-05-10 |
| IE914183A1 (en) | 1992-06-03 |
| ES2119752T3 (es) | 1998-10-16 |
| DE69129790T2 (de) | 1999-05-06 |
| DK0489379T3 (da) | 1999-04-19 |
| DE69129790D1 (de) | 1998-08-20 |
| PT99674A (pt) | 1992-10-30 |
| EP0489379A1 (en) | 1992-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI901447A0 (fi) | Menetelmä farmakologisesti aktiivisten 8-substituoitujen ksantiinijohdannaisten valmistamiseksi | |
| EP0256503A3 (en) | Pyridinecarboxamide derivatives and their use as fungicide | |
| DE69021755D1 (de) | Benzopyranderivate und Verfahren zu ihrer Herstellung. | |
| DK0437030T3 (da) | Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk | |
| PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
| NO892295D0 (no) | Fremgangsmaate for fremstilling av nye cefemforbindelser. | |
| DK291488D0 (da) | Alkansulfonanilidderivater | |
| PT87277A (pt) | Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same | |
| ATE89739T1 (de) | Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. | |
| ATE86866T1 (de) | Antikrebs-zusammensetzung. | |
| NO914734L (no) | 5-amino-5,6,7,8-tetrahydrokinoliner og beslektede forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter | |
| HUT50337A (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds | |
| FI911138A0 (fi) | Ny substituerad aminfoerening och foerfarande foer dess framstaellning. | |
| FI935798A0 (fi) | Alkylsubstituerade heterocykliska foereningar | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| ATE79259T1 (de) | Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung. | |
| MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. |